Arkray‘s U.S. business has inked a licensing deal with Mellitus Healthfor its insulin titration software, Insulin Insights.
Mellitus Health, formerly known as Insulin Algorithms, developed the clinical decision-support tool to help doctors keep their patients’ blood sugar levels in control with optimized insulin therapy. The software is compatible with any blood glucose monitoring system and with all brands of insulin.
Get the full story at our sister site, Drug Delivery Business News.
The post Arkray inks licensing deal with Mellitus Health for insulin titration software appeared first on MassDevice.
from MassDevice http://ift.tt/2nvXTpn
Cap comentari:
Publica un comentari a l'entrada